Search results for "Oncogene"

showing 10 items of 1005 documents

Expression of Transketolase-like 1 and Activation of Akt in Grade IV Glioblastomas Compared With Grades II and III Astrocytic Gliomas

2008

Transketolases link the Embden-Meyerhof pathway to the pentose phosphate pathway. An influence of p-Akt on this metabolism was described. This study was performed to compare the expression of transketolase-like 1 (TKTL1) and p-Akt in glioblastoma multiforme (GBM) and other astrocytic gliomas (AGs, grades II and III). We analyzed 15 GBMs, 15 AGs (grade II), and 3 normal brain samples for TKTL1 expression by semiquantitative reverse transcription–polymerase chain reaction and Western blotting and 23 GBMs, 9 grade III AGs, and 7 grade II AGs immunohistochemically (TKTL1 and p-Akt). On the protein level, TKTL1 was significantly overexpressed in tumors. Immunohistochemically, the tumor grade sig…

Pathologymedicine.medical_specialtyAstrocytomaGeneral MedicineMetabolismAstrocytomaPentose phosphate pathwayTransketolaseBiologymedicine.diseaseEnzyme assayUp-RegulationEnzyme ActivationGene Expression Regulation NeoplasticBlotmedicinebiology.proteinCancer researchHumansGlycolysisRNA MessengerTransketolaseGlioblastomaProto-Oncogene Proteins c-aktProtein kinase BAmerican Journal of Clinical Pathology
researchProduct

Gastrointestinal stromal tumors (GISTs): Focus on histopathological diagnosis and biomolecular features

2007

Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the gastrointestinal tract that are believed to originate from a neoplastic transformation of the intestinal pacemaker cells (interstitial cells of Cajal) normally found in the bowel wall or their precursors. Although the microscopic features have been known for a long time, the defining characteristic of GIST is the presence of the cell-surface antigen CD117 (KIT), which is demonstrated by immunohistochemistry. KIT, which is a growth factor transmembrane receptor, is the product of the proto-oncogene c-kit (chromosome 4). Surgical removal remains the only curative treatment for patients with GISTs. Tumor size, mitotic index,…

Pathologymedicine.medical_specialtyGastrointestinal Stromal TumorsPDGFRAProto-Oncogene MasHumansMedicineGastrointestinal stromal tumors; Histopathological diagnosis; Molecular biology; Novel therapies; Drug Resistance Neoplasm; Gastrointestinal Stromal Tumors; Humans; Hematology; OncologyNeoplastic transformationGastrointestinal stromal tumors (GISTs)neoplasmsbiologyGiSTbusiness.industryCD117SunitinibImatinibHematologymedicine.diseasedigestive system diseasesImatinib mesylateOncologyDrug Resistance Neoplasmbiology.proteinCancer researchbusinessmedicine.drug
researchProduct

Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease

2001

BACKGROUNDHirschsprung disease (HSCR) is a frequent congenital disorder with an incidence of 1 in 5000 live births, characterised by the absence of parasympathetic intramural ganglion cells in the hindgut resulting in intestinal obstruction in neonates and severe constipation in infants and adults. Intestinal neuronal dysplasia (IND) shares clinical features with HSCR but the submucosal parasympathetic plexus is affected. IND has been proposed as one of the most frequent causes of chronic constipation and is often associated with HSCR.METHODSWe examined 29 patients diagnosed with sporadic HSCR, 20 patients with IND, and 12 patients with mixed HSCR/IND for mutations in the coding regions of …

Pathologymedicine.medical_specialtyGlial Cell Line-Derived Neurotrophic Factor ReceptorsHirschsprung diseaseMUTATION ANALYSISNerve Tissue ProteinsTYROSINE KINASEEDNRBArticleExonGermline mutationProto-Oncogene ProteinsNEUROTROPHIC FACTOR GDNFmedicineGlial cell line-derived neurotrophic factorDrosophila ProteinsHumansGlial Cell Line-Derived Neurotrophic FactorNerve Growth FactorsAlleleintestinal neuronal dysplasiaAllelesPolymorphism Single-Stranded ConformationalIntestinal neuronal dysplasiabiologyReceptors EndothelinSHAH-WAARDENBURG SYNDROMEProto-Oncogene Proteins c-retENDOTHELIN-B-RECEPTORMULTIGENIC INHERITANCEGastroenterologyReceptor Protein-Tyrosine KinasesSequence Analysis DNAGERMLINE MUTATIONSbiochemical phenomena metabolism and nutritionPROTOONCOGENEmedicine.diseasePHENOTYPIC-EXPRESSIONGDNFPedigreeProto-Oncogene Proteins c-retDysplasiaCase-Control StudiesMutationbiology.proteinLIGANDRETCongenital disorderEDN3
researchProduct

An in vitro study showing the three-dimensional microenvironment influence over the behavior of head and neck squamous cell carcinoma

2011

Objectives: The Head and Neck Squamous Cell Carcinoma (HNSCC) ranks sixth worldwide. The mechanisms of growth, invasion and metastasis of this pathology are extensively studied and generally related to specific variations in signaling pathways like the PI3K-Akt; however most of these competent studies have been performed bidimensionally, which may hide important questions. This study sought to analyze the influence of the microenvironment upon the behavior of HNSCC. Study Design: The status of pAkt, NF-κB and Cyclin D1 proteins was accessed through immunofluorescence and western blot methods in HNSCC cell lines originating from tongue, pharynx and metastatic lymph node when submitted to a t…

Pathologymedicine.medical_specialtyImmunofluorescenceMetastasisCyclin D1Western blotTumor Cells CulturedTumor MicroenvironmentmedicineHumansCyclin D1Epidermal growth factor receptorGeneral DentistryOral Medicine and Pathologymedicine.diagnostic_testbiologySquamous Cell Carcinoma of Head and NeckNF-kappa B:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseHead and neck squamous-cell carcinomaOtorhinolaryngologyHead and Neck NeoplasmsCell cultureUNESCO::CIENCIAS MÉDICASCarcinoma Squamous CellCancer researchbiology.proteinResearch-ArticleSurgerySignal transductionProto-Oncogene Proteins c-aktMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Kit Is Expressed by Epithelial Cells In Vivo

2003

In mammalian skin, stem cell factor (SCF) regulates the proliferation and maturation of mast cells and melanocytes, which are thought to be the only cutaneous cells that express the Kit-tyrosine kinase receptor (Kit) and respond to epithelial and mesenchymal-derived SCF. We previously had noted, however, the presence of Kit+ cells in murine hair follicles, in an introepithelial tissue compartment devoid of melanocytes and mast cells. Here we have identified the nature of this Kit+ population of cells in hair follicles of C57BL/6 mice. Anagen hair follicles showed strong Kit immunoreactivity not only in the pigmentary unit above the follicular dermal papilla but also in a much more proximall…

Pathologymedicine.medical_specialtyPopulationStem cell factorDermatologyBiochemistryMicemedicineAnimalseducationMolecular BiologyMelanosomeKit-neutralizing antibodyOncogene ProteinsStem Cell Factoreducation.field_of_studyhair cycling6 mouseintegumentary systembiologyDesmoplakinSCFEpithelial CellsCell BiologyHair follicleImmunohistochemistryMolecular biologyEpitheliumMice Inbred C57BLC57BLProto-Oncogene Proteins c-kitmedicine.anatomical_structureDermal papillaeepithelial cell biologybiology.proteinProto-Oncogene Proteins c-kitFemaleHair FollicleSignal TransductionJournal of Investigative Dermatology
researchProduct

C-erbB-2-oncogene expression in breast carcinoma: Analysis by S1 nuclease protection assay and immunohistochemistry in relation to clinical parameters

1992

The c-erbB-2 mRNA was detected by the S1 nuclease protection assay and Northern blotting in breast cancer tissues. In contrast to the Northern blot analysis which has been used in all recent publications concerning c-erbB-2 expression on the level of RNA, the S1-nuclease protection assay has distinct advantages with respect to sensitivity, reproducibility, and handling of radioactive probes. We compared the expression of c-erbB-2 in 120 breast carcinomas which were operated in the years 1989-1990 on the level of the mRNA (S1 nuclease protection assay) and the protein (immunohistochemistry), respectively. In general, results obtained with both methods were in good agreement. Only minor diffe…

Pathologymedicine.medical_specialtyReceptor ErbB-2Breast NeoplasmsBiologyGene Expression Regulation EnzymologicImmunoenzyme TechniquesBreast cancerProto-Oncogene ProteinsGene expressionmedicineHumansRNA NeoplasmNorthern blotskin and connective tissue diseasesLymph nodeOncogeneSingle-Strand Specific DNA and RNA EndonucleasesObstetrics and GynecologyBlotting Northernmedicine.diseaseSurvival AnalysisGene Expression Regulation NeoplasticBlotmedicine.anatomical_structureOncologyCancer researchImmunohistochemistryFemaleBreast carcinomaGynecologic Oncology
researchProduct

Immunohistochemical expression of Bcl-2 in benign and malignant salivary gland tumors

2010

Objectives: The present study was undertaken to assess and compare the immunohistochemical expression of Bcl-2 in selected benign and malignant salivary gland tumors. Study Design: A total of 50 cases of buffered formalin-fixed, paraffin embedded tissues of previously diagnosed cases of benign and malignant salivary gland tumors from the archives of Department of Oral and Maxillofacial Pathology and Microbiology, SDM College of Dental Sciences and Hospital, Dharwad, India, were taken for the study. The immunohistochemical staining procedure was performed using monoclonal anti Bcl-2 antibody, as directed by the manufacturer. Results: Thirty six cases (72%) out of 50 cases showed a positive e…

Pathologymedicine.medical_specialtySalivary glandbusiness.industryCanalicular adenomamedicine.diseaseSalivary Gland Neoplasms:CIENCIAS MÉDICAS [UNESCO]ImmunohistochemistryStainingGene Expression Regulation Neoplasticmedicine.anatomical_structureOtorhinolaryngologyProto-Oncogene Proteins c-bcl-2Oral and maxillofacial pathologyMonoclonalUNESCO::CIENCIAS MÉDICASmedicineImmunohistochemistryHumansSurgerybusinessGeneral DentistrySurvival rateLymph node
researchProduct

SOX2 and BCL-2 Expressions in Odontogenic Keratocyst and Ameloblastoma

2020

Background The purpose of this experimental study was to compare the immunohistochemical expression of SOX2 and BCL-2 in Odontogenic Keratocyst (OKC) and Ameloblastoma (AB) specimens, and to identify a possible correlation in their expression. Material and Methods Immunohistochemical analysis was performed to evaluate SOX2 and BCL-2 expression in OKC (n = 20) and AB (n = 20). The immunoexpression was analyzed by a quantitative and qualitative scoring system. The comparison between the immunoexpression of SOX 2 and BCL-2 was assessed by the Mann-Whitney U-test. Spearman’s correlation coefficient evaluated the correlation between SOX2 and BCL-2 expressions. Results SOX2 and BCL-2 expression w…

Pathologymedicine.medical_specialtyScoring systemOdontogenic TumorsBiologyAmeloblastoma03 medical and health sciences0302 clinical medicineSOX2stomatognathic systemmedicineHumansKeratocystAmeloblastomaGeneral DentistryOral Medicine and PathologyResearchSOXB1 Transcription Factors030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]OdontogenicOtorhinolaryngologyProto-Oncogene Proteins c-bcl-2UNESCO::CIENCIAS MÉDICASembryonic structuresOdontogenic CystsImmunohistochemistrySurgeryFull thicknessmedicine.symptomImmunostainingMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Prognostic significance of c-erB-2 mRNA in ovarian carcinoma.

1996

The oncogene specific mRNA of c-erbB-2 was detected by the S1 nuclease protection assay in 95 ovarian cancer specimens. In 79 primary carcinomas, we found 16 (20%) with strong expression, 13 (17%) with weak expression, 4 (5%) with very weak expression, and 46 (58%) with no expression. In 3 of 16 recurrencies (19%) a strong expression of c-erbB-2 mRNA was detected, in 2 (12%) weak expression was detected, and in 11 (69%) no expression of c-erbB-2 mRNA was detected. Kaplan-Meier analysis revealed no significant association between strong expression of c-erbB-2 mRNA and survival of the 79 patients with primary cancer. However, in the subgroup of patients with FIGO (International Federation of …

Pathologymedicine.medical_specialtySerous carcinomaReceptor ErbB-2OvaryAndrologyPredictive Value of TestsOvarian carcinomamedicineCarcinomaHumansRNA MessengerRNA NeoplasmStage (cooking)neoplasmsNeoplasm StagingOvarian NeoplasmsMessenger RNAOncogenebusiness.industryObstetrics and Gynecologymedicine.diseasePrognosisSurvival AnalysisUp-RegulationGene Expression Regulation Neoplasticmedicine.anatomical_structureOncologyFemaleOvarian cancerbusinessGynecologic oncology
researchProduct

Bone Metastasis in Renal Cell Carcinoma is Preprogrammed in the Primary Tumor and Caused by AKT and Integrin α5 Signaling

2015

Bone metastasis develops in 30% of all patients with renal cell carcinoma. We elucidated the mechanisms that lead to and predict bone metastasis of renal cell carcinoma.Nine renal cell carcinoma primary cell lines and 30 renal cell carcinoma tissue specimens (normal and tumor tissue) were collected from 3 patients with no metastasis and 10 with lung or bone metastasis within 5 years after nephrectomy. Cell migration was analyzed in a Boyden chamber and proliferation was assessed by bromodeoxyuridine incorporation. Adhesion to fibronectin, and collagen I and IV was determined after cell staining. The expression and/or activity of cellular signaling molecules was quantified by Western blot.Co…

Pathologymedicine.medical_specialtyUrologyBlotting WesternBone NeoplasmsIntegrin alpha5MetastasisExtracellular matrixCell MovementRenal cell carcinomaCell Line TumormedicineCarcinomaHumansCarcinoma Renal CellKidneybiologybusiness.industryTumor Suppressor ProteinsPTEN PhosphohydrolaseBone metastasisCell migrationDNA Neoplasmmedicine.diseaseKidney NeoplasmsGene Expression Regulation NeoplasticFibronectinmedicine.anatomical_structurebiology.proteinCancer researchbusinessProto-Oncogene Proteins c-aktSignal TransductionJournal of Urology
researchProduct